Lower brain and blood nutrient status in Alzheimer's disease: Results from meta‐analyses
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Introduction: Alzheimer's disease (AD) patients are at risk of nutritional insufficiencies because of physiological and psychological factors. Recently, we showed the results of the meta‐analyses indicating lower plasma levels of vitamins A, B 12 , C, E, and folate in AD patients compared with cognitively intact elderly controls (controls). Now, additional and more extensive literature searches were performed selecting studies which compare blood and brain/cerebrospinal fluid (CSF) levels of vitamins, minerals, trace elements, micronutrients, and fatty acids in AD patients versus controls. Methods: The literature published after 1980 in Cochrane Central Register of Controlled Trials, Medline, and Embase electronic databases was systematically analyzed using Preferred Reporting Items for Systematic reviews and Meta‐Analyses guidelines to detect studies meeting the selection criteria. Search terms used are as follows: AD patients, Controls, vitamins, minerals, trace elements, micronutrients, and fatty acids. Random‐effects meta‐analyses using a linear mixed model with correction for age differences between AD patients and controls were performed when four or more publications were retrieved for a specific nutrient. Results: Random‐effects meta‐analyses of 116 selected publications showed significant lower CSF/brain levels of docosahexaenoic acid (DHA), choline‐containing lipids, folate, vitamin B 12 , vitamin C, and vitamin E. In addition, AD patients showed lower circulatory levels of DHA, eicosapentaenoic acid, choline as phosphatidylcholine, and selenium. Conclusion: The current data show that patients with AD have lower CSF/brain availability of DHA, choline, vitamin B 12 , folate, vitamin C, and vitamin E. Directionally, brain nutrient status appears to parallel the lower circulatory nutrient status; however, more studies are required measuring simultaneously circulatory and central nutrient status to obtain better insight in this observation. The brain is dependent on nutrient supply from the circulation, which in combination with nutrient involvement in AD‐pathophysiological mechanisms suggests that patients with AD may have specific nutritional requirements. This hypothesis could be tested using a multicomponent nutritional intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
Tönnies, E., & Trushina, E. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161088 · Cited by 1,750 · cited 1×
“Third, multiple lines of evidence provide strong support for the involvement of oxidative stress in the development of AD [199].”
BackgroundZhao, Q.-F., Tan, L., Wang, H.-F., Jiang, T., Tan, M.-S., Tan, L., Xu, W., Li, J.-Q., Wang, J., Lai, T.-J., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.069 · Cited by 916
Vitamin B12, folic acid, and the nervous system
Reynolds, E. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70598-1 · Cited by 860
Vitamin A metabolism: An update
D’Ambrosio, D. N., Clugston, R. D., & Blaner, W. S. (2011) · Nutrients · doi:10.3390/nu3010063 · Cited by 562
Trushina, E., Dutta, T., Persson, X.-M. T., Mielke, M. M., & Petersen, R. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063644 · Cited by 438 · cited 2×
“The affected pathways range from fatty acidmetabolism, one-carbon metabolism, energy metabolism, Krebs cycle, mitochondrial function, nucleic acid metabolism, but also neurotransmitter and amino acid metabolism, and lipid biosynthesis [165,166].”
BackgroundHan, X., Rozen, S., Boyle, S. H., Hellegers, C., Cheng, H., Burke, J. R., Welsh-Bohmer, K. A., Doraiswamy, P. M., & Kaddurah-Daouk, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021643 · Cited by 429
Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study
Schrijvers, E. M. C., Witteman, J. C. M., Sijbrands, E. J. G., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ffe4f6 · Cited by 328 · cited 1×
“[141]; [5] recent meta-analysis for circulatory”
White, H., Pieper, C., & Schmader, K. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb04537.x · Cited by 323
Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall
Getz, G. S., & Reardon, C. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800058-jlr200 · Cited by 319
Zhao, Y., Calon, F., Julien, C., Winkler, J. W., Petasis, N. A., Lukiw, W. J., & Bazan, N. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015816 · Cited by 243 · cited 1×
“For example, the neuroprotective and regenerative properties of DHA-derived neuroprotectin D1 bioactivity potently downregulate inflammatory signaling, amyloidogenic APP cleavage and apoptosis [201], and inflammation in peripheral blood mononuclear cells from AD patients [202].”
BackgroundPathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease
Overk, C. R., & Masliah, E. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.015 · Cited by 242 · cited 1×
“Indeed, AD is associated with loss of synaptic function and lower synapse numbers [183,184], and these changes are the major correlates of cognitive impairment observed in AD [185].”
BackgroundAstarita, G., Jung, K.-M., Berchtold, N. C., Nguyen, V. Q., Gillen, D. L., Head, E., Cotman, C. W., & Piomelli, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012538 · Cited by 218 · cited 2×
“Unfortunately, the systematic literature search did not yield sufficient number of publications reporting on brain EPA (three studies [61,66,69]), vitamin A (zero studies), vitamin B1 (zero studies), vitamin B6 (zero studies), vitamin D (one study [144]), calcium (two studies [59,134]), magnesium (two studies, see Ver…”
BackgroundREVIEW: Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E
Spector, R., & Johanson, C. E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04773.x · Cited by 175
Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease
Molina, J. A., Jiménez-Jiménez, F. J., Aguilar, M. V., Meseguer, I., Mateos-Vega, C. J., González-Muñoz, M. J., de Bustos, F., Porta, J., Ortí-Pareja, M., Zurdo, M., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050071 · Cited by 167 · cited 1×
“[141]), and manganese (three studies [123,135,137]).”
Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review
Canhada, S., Castro, K., Perry, I. S., & Luft, V. C. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1321813 · Cited by 156
Brain Glutamate Levels Are Decreased in Alzheimer’s Disease: A Magnetic Resonance Spectroscopy Study
Fayed, N., Modrego, P. J., Rojas-Salinas, G., & Aguilar, K. (2011) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317511421780 · Cited by 128
van Wijk, N., Broersen, L. M., de Wilde, M. C., Hageman, R. J. J., Groenendijk, M., Sijben, J. W. C., & Kamphuis, P. J. G. H. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130998 · Cited by 128
Self-citationLow Plasma N-3 Fatty Acids and Dementia in Older Persons: The InCHIANTI Study
Cherubini, A., Andres-Lacueva, C., Martin, A., Lauretani, F., Iorio, A. D., Bartali, B., Corsi, A., Bandinelli, S., Mattson, M. P., & Ferrucci, L. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.10.1120 · Cited by 95
Zinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders
Kapaki, E., Segditsa, J., & Papageorgiou, C. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb03803.x · Cited by 92
Rai, V. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9722-8 · Cited by 88
Magnesium Status in Alzheimer’s Disease: A Systematic Review
Veronese, N., Zurlo, A., Solmi, M., Luchini, C., Trevisan, C., Bano, G., Manzato, E., Sergi, G., & Rylander, R. (2016) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317515602674 · Cited by 64
Cited by
Djuricic, I., & Calder, P. C. (2021) · Nutrients · doi:10.3390/nu13072421 · Cited by 1,015
Alzheimer’s disease: risk factors and potentially protective measures
Silva, M. V. F., Loures, C. D. M. G., Alves, L. C. V., de Souza, L. C., Borges, K. B. G., & Carvalho, M. D. G. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0524-y · Cited by 937
Ageing, age-related diseases and oxidative stress: What to do next?
Luo, J., Mills, K., le Cessie, S., Noordam, R., & van Heemst, D. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100982 · Cited by 581
Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
Chew, H., Solomon, V. A., & Fonteh, A. N. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00598 · Cited by 353
Blood–Brain Barrier Dynamics to Maintain Brain Homeostasis
Segarra, M., Aburto, M. R., & Acker-Palmer, A. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2020.12.002 · Cited by 300
Metadata
- Authors
- de Wilde, M. C., Vellas, B., Girault, E., Yavuz, A. C., & Sijben, J. W.
- Venue
- Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Publisher
- Wiley
- Published
- 2017-06-26
- Volume
- 3
- Issue
- 3
- Pages
- 416-431
- ISSN
- 2352-8737 (ISSN-L)
- OpenAlex
- W2630041514
- Cited by
- 135
- References
- 23
- FWCI
- 11.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.